Lifecore Biomedical Accounts Payable

Lifecore Biomedical posts a accounts payable of $7.5M as of June 2026. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

Accounts Payable is one piece of Lifecore Biomedical's financial statement story. At $7.5M, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for LFCR's accounts payable usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; Lifecore Biomedical's other metric pages and overview cover the third.

Judging Lifecore Biomedical against Materials peers is usually better than using a market-wide rule of thumb. Business models inside Materials are more comparable, which makes gaps in accounts payable easier to interpret. Start with $7.5M here, then scan peer and history charts to see if the gap is persistent.